Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Syphilis can cause hair loss even without penetrative sex, but treatment can fully restore hair.

Ectodermal dysplasia causes various symptoms and early treatment is important for eye, dental, and skin issues.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Fullerenes show potential in skin care but need more safety research.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Erlotinib can cause hair loss as a side effect.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Various treatments exist for hair loss, but more research is needed for better options.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Bimatoprost increases hair growth in mice without breaking down into other substances.

The document concludes that skin grafts are essential for repairing tissue loss, with various types available and ongoing research into substitutes to improve outcomes and reduce donor site issues.